Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Eyes Food Traceability Marketplace

NEW YORK, Dec. 31 (GenomeWeb News) -- Orchid BioSciences plans to enter the DNA-based food traceability market, the company said in a statement today.


The Princeton, NJ-based company, which currently conducts a food safety business that focuses on disease-susceptibility and DNA identity testing of animals, said it plans to take advantage of its existing laboratory infrastructure, which this year tested over a half a million sheep in a high-throughput facility in the UK, and its SNP genotyping processes, to begin the new marketing effort.


Orchid is a market leader in providing susceptibility genotyping testing for scrapie, a neurodegenerative disease characterized by the accumulation of prions, an abnormal protein in the brains of affected sheep, similar to bovine spongiform encephalopathy in cattle, and Creutzfeldt-Jakob disease in humans.


The company said it plans to make its first meat identification assays available as part of its services in 2004.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.